株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

核画像診断装置:医療機器のパイプライン評価

Nuclear Imaging Equipment - Medical Devices Pipeline Assessment, 2019

発行 GlobalData 商品コード 633278
出版日 ページ情報 英文 192 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.69円で換算しております。
Back to Top
核画像診断装置:医療機器のパイプライン評価 Nuclear Imaging Equipment - Medical Devices Pipeline Assessment, 2019
出版日: 2019年05月01日 ページ情報: 英文 192 Pages
概要

当レポートでは、世界の核画像診断装置の市場における、主要なパイプライン製品 (医療機器) とその治験の進行状況について調査すると共に、製品特性の比較分析 (治験の進行段階別) や、主要企業のプロファイルおよび代表的製品、昨今の市場動静 (資本取引・事業提携など) といった情報を取りまとめてお届けいたします。

第1章 目次

第2章 イントロダクション

  • 核画像診断装置の概要

第3章 現在治験中の製品

  • パイプライン製品:治験段階別
  • パイプライン製品:部門別
  • パイプライン製品:領域別
  • パイプライン製品:規制経路別
  • パイプライン製品:推定認証時期別
  • 現在進行中の治験

第4章 核画像診断装置:各企業で現在治験中のパイプライン製品

  • 核画像診断装置企業:治験段階別のパイプライン製品
  • 核画像診断装置:治験段階別のパイプライン製品

第5章 核画像診断装置の企業・製品の概要

  • Brain Biosciences Inc
  • ELECTRON Ltd.
  • Emory University
  • EXINI Diagnostics AB
  • FMI Technologies, Inc.
  • GE Healthcare LLC
  • General De Equipment for Medical Imaging SA
  • IntraMedical Imaging LLC
  • Jagiellonian University
  • Lightpoint Medical Ltd
  • Memorial Sloan Kettering Cancer Center
  • Molecular Dynamics
  • Philips Healthcare
  • PulmoScience, Inc.
  • Ray Vision Intl Corp.
  • Siemens AG
  • Siemens Healthcare GmbH
  • Stanford University
  • Symetrica Security Ltd
  • SynchroPET
  • University of Arizona
  • University of British Columbia
  • University of California Davis
  • University of the Witwatersrand
  • University of Washington
  • West Virginia University
  • Zecotek Photonics Inc
  • Zumatek Inc

第6章 核画像診断装置市場:昨今の動向

第7章 付録

図表

1.1 List of Tables

  • Table 1: Nuclear Imaging Equipment - Pipeline Products by Stage of Development
  • Table 2: Nuclear Imaging Equipment - Pipeline Products by Segment
  • Table 3: Nuclear Imaging Equipment - Pipeline Products by Territory
  • Table 4: Nuclear Imaging Equipment - Pipeline Products by Regulatory Path
  • Table 5: Nuclear Imaging Equipment - Pipeline Products by Estimated Approval Date
  • Table 6: Nuclear Imaging Equipment - Ongoing Clinical Trials
  • Table 7: Nuclear Imaging Equipment Companies - Pipeline Products by Stage of Development
  • Table 8: Nuclear Imaging Equipment - Pipeline Products by Stage of Development
  • Table 9: Brain Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: CerePET - Product Status
  • Table 11: CerePET - Product Description
  • Table 12: FREEMotion - Product Status
  • Table 13: FREEMotion - Product Description
  • Table 14: ELECTRON Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 15: Complex Isotope Diagnostics Device - Product Status
  • Table 16: Complex Isotope Diagnostics Device - Product Description
  • Table 17: Emory University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 18: PET/CT Total Body Scan - Product Status
  • Table 19: PET/CT Total Body Scan - Product Description
  • Table 20: EXINI Diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview
  • Table 21: EXINI PET - Product Status
  • Table 22: EXINI PET - Product Description
  • Table 23: FMI Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 24: ScintiStar Neuro 100 PET/CT/SPECT - Product Status
  • Table 25: ScintiStar Neuro 100 PET/CT/SPECT - Product Description
  • Table 26: ScintiStar Neuro 200 PET/CT/SPECT - Product Status
  • Table 27: ScintiStar Neuro 200 PET/CT/SPECT - Product Description
  • Table 28: GE Healthcare LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 29: Discovery MI - Product Status
  • Table 30: Discovery MI - Product Description
  • Table 31: Q.Clear - Product Status
  • Table 32: Q.Clear - Product Description
  • Table 33: General De Equipment for Medical Imaging SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 34: CareMiBrain - Product Status
  • Table 35: CareMiBrain - Product Description
  • Table 36: IntraMedical Imaging LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 37: Marginator Beta Camera - Product Status
  • Table 38: Marginator Beta Camera - Product Description
  • Table 39: Jagiellonian University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 40: Positron Emission Tomography System - Product Status
  • Table 41: Positron Emission Tomography System - Product Description
  • Table 42: Lightpoint Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 43: HARLI - Product Status
  • Table 44: HARLI - Product Description
  • Table 45: Memorial Sloan Kettering Cancer Center Pipeline Products & Ongoing Clinical Trials Overview
  • Table 46: Micro-NMR System - Product Status
  • Table 47: Micro-NMR System - Product Description
  • Table 48: Molecular Dynamics Pipeline Products & Ongoing Clinical Trials Overview
  • Table 49: Valiance X12 - Product Status
  • Table 50: Valiance X12 - Product Description
  • Table 51: Molecular Dynamics - Ongoing Clinical Trials Overview
  • Table 52: Valiance X12 - Molecular Dynamics' Innovative Whole-body CZT Digital SPECT/CT Trial
  • Table 53: Neurovation Labs Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 54: NVL1 Diagnostic Tracer - Product Status
  • Table 55: NVL1 Diagnostic Tracer - Product Description
  • Table 56: Neusoft Medical Systems Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 57: NeuWise PET/CT - Product Status
  • Table 58: NeuWise PET/CT - Product Description
  • Table 59: Nuclear, Plasma, and Radiological Engineering Pipeline Products & Ongoing Clinical Trials Overview
  • Table 60: Head And Neck PET System - Product Status
  • Table 61: Head And Neck PET System - Product Description
  • Table 62: Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview
  • Table 63: Additional PET Scan - Product Status
  • Table 64: Additional PET Scan - Product Description
  • Table 65: PET/CT Scanner - Myocardial Perfusion Assessment - Product Status
  • Table 66: PET/CT Scanner - Myocardial Perfusion Assessment - Product Description
  • Table 67: PulmoScience, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 68: PulmoBind - Product Status
  • Table 69: PulmoBind - Product Description
  • Table 70: Ray Vision Intl Corp. Pipeline Products & Ongoing Clinical Trials Overview

1.2 List of Figures

  • Figure 1: Nuclear Imaging Equipment - Pipeline Products by Stage of Development
  • Figure 2: Nuclear Imaging Equipment - Pipeline Products by Segment
  • Figure 3: Nuclear Imaging Equipment - Pipeline Products by Territory
  • Figure 4: Nuclear Imaging Equipment - Pipeline Products by Regulatory Path
  • Figure 5: Nuclear Imaging Equipment - Pipeline Products by Estimated Approval Date
  • Figure 6: Nuclear Imaging Equipment - Ongoing Clinical Trials
目次
Product Code: GDME0769EPD

GlobalData's Medical Devices sector report, "Nuclear Imaging Equipment - Medical Devices Pipeline Assessment, 2019" provides an overview of Nuclear Imaging Equipment currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Nuclear Imaging Equipment pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Nuclear Imaging Equipment under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Nuclear Imaging Equipment and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Nuclear Imaging Equipment under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date.

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

  • 2.1 Nuclear Imaging Equipment Overview

3 Products under Development

  • 3.1 Nuclear Imaging Equipment - Pipeline Products by Stage of Development
  • 3.2 Nuclear Imaging Equipment - Pipeline Products by Segment
  • 3.3 Nuclear Imaging Equipment - Pipeline Products by Territory
  • 3.4 Nuclear Imaging Equipment - Pipeline Products by Regulatory Path
  • 3.5 Nuclear Imaging Equipment - Pipeline Products by Estimated Approval Date
  • 3.6 Nuclear Imaging Equipment - Ongoing Clinical Trials

4 Nuclear Imaging Equipment - Pipeline Products under Development by Companies

  • 4.1 Nuclear Imaging Equipment Companies - Pipeline Products by Stage of Development
  • 4.2 Nuclear Imaging Equipment - Pipeline Products by Stage of Development

5 Nuclear Imaging Equipment Companies and Product Overview

  • 5.1 Brain Biosciences Inc Company Overview
  • 5.2 ELECTRON Ltd. Company Overview
  • 5.3 Emory University Company Overview
  • 5.4 EXINI Diagnostics AB Company Overview
  • 5.5 FMI Medical Systems Inc Company Overview
  • 5.6 GE Healthcare LLC Company Overview
  • 5.7 General De Equipment for Medical Imaging SA Company Overview
  • 5.8 IntraMedical Imaging LLC Company Overview
  • 5.9 Jagiellonian University Company Overview
  • 5.10 Lightpoint Medical Ltd Company Overview
  • 5.11 Memorial Sloan Kettering Cancer Center Company Overview
  • 5.12 Molecular Dynamics Company Overview
  • 5.13 Neurovation Labs Inc Company Overview
  • 5.14 Neusoft Medical Systems Co Ltd Company Overview
  • 5.15 Nuclear, Plasma, and Radiological Engineering Company Overview
  • 5.16 Philips Healthcare Company Overview
  • 5.17 PulmoScience, Inc. Company Overview
  • 5.18 Ray Vision Intl Corp. Company Overview
  • 5.19 Shanghai United Imaging Healthcare Co Ltd Company Overview
  • 5.20 Siemens Healthineers AG Company Overview
  • 5.21 Stanford University Company Overview
  • 5.22 Symetrica Security Ltd Company Overview
  • 5.23 SynchroPET Company Overview
  • 5.24 University of Arizona Company Overview
  • 5.25 University of British Columbia Company Overview
  • 5.26 University of California Davis Company Overview
  • 5.27 University of California Los Angeles Company Overview
  • 5.28 University of the Witwatersrand Company Overview
  • 5.29 University of Washington Company Overview
  • 5.30 West Virginia University Company Overview
  • 5.31 Zecotek Photonics Inc Company Overview
  • 5.32 Zumatek Inc Company Overview

6 Nuclear Imaging Equipment- Recent Developments

  • 6.1 Apr 08, 2019: SNMMI and ACR Collaborate on Clinical Data Registry for Nuclear Medicine
  • 6.2 Mar 25, 2019: EDP and European Commission promote deals between startups and global companies
  • 6.3 Mar 25, 2019: Inflazome receives funding from The Michael J. Fox Foundation for Parkinson's Research
  • 6.4 Mar 19, 2019: Concord Medical announces new appointments to the management team
  • 6.5 Mar 18, 2019: European Association of Urology issues updated guidelines for prostate cancer imaging
  • 6.6 Mar 11, 2019: MedShare to launch partnership with Philips to deliver biomedical equipment to medically underserved communities
  • 6.7 Mar 11, 2019: New Tracers Improve Diagnosis of Cancer and May Be Useful for Treatment
  • 6.8 Mar 07, 2019: Navidea Biopharmaceuticals reports fourth quarter and full year 2018 financial results
  • 6.9 Mar 01, 2019: Digirad reports financial results for the fourth quarter and twelve months ended December 31, 2018

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer
Back to Top